IP Verse

Sanofi-Aventis Groupe S.A. vs. Amgen Inc. - APL_572929/2023

Explore detailed information on the case number APL_572929/2023 involving Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., and others and Amgen Inc. which was filed on 13 Sep, 2023.

Case Details

    Case Number:

    APL_572929/2023

    Filing Date:

    13 Sep, 2023

    Proceeding Type:

    Appeal

    Action/Application:

    Appeal Rop220.2

    Decision Number:

    Ecli:Eu:Up:2023:580110

    Decision Date:

    16 Oct, 2023

    Plaintiffs:

    • Sanofi-Aventis Groupe S.A. Represented By Niels Hoelder
    • Regeneron Pharmaceuticals Inc. Represented By Niels Hoelder
    • Sanofi Winthrop Industrie S.A. Represented By Niels Hoelder
    • Sanofi-Aventis Deutschland Gmbh Represented By Niels Hoelder

    Defendants:

    • Amgen Inc. Represented By Johannes Heselberger

    Judges:

    • Ingeborg Simonsson
    • Patricia Rombach
    • Rian Kalden

    Court Division:

    Appeal Instance - Seat - Luxembourg

Case Decision

More cases on Sanofi-Aventis Groupe S.A.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
CC_586764/2023Regeneron Pharmaceuticals Inc.Amgen Inc.
ACT_597355/2023Sanofi Biotechnologies Sas, Regeneron Pharmaceuticals Inc.Amgen Inc., Amgen Gmbh, Amgen Europe B.V., Amgen Nv, Amgen S.R.L., Amgen B.V., Amgen S.A.S.
ACT_10334/2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.

More cases on Amgen Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
CC_586764/2023Regeneron Pharmaceuticals Inc.Amgen Inc.
ACT_597355/2023Sanofi Biotechnologies Sas, Regeneron Pharmaceuticals Inc.Amgen Inc., Amgen Gmbh, Amgen Europe B.V., Amgen Nv, Amgen S.R.L., Amgen B.V., Amgen S.A.S.
ACT_10334/2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.